Stock MOH MOLINA HEALTHCARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Molina Healthcare, Inc.

Equities

MOH

US60855R1005

Managed Healthcare

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
314.6 USD +2.79% Intraday chart for Molina Healthcare, Inc. -5.28% -12.93%
May. 30 JPMorgan Adjusts Price Target on Molina Healthcare to $420 From $435 MT
May. 30 Baird Initiates Molina Healthcare With Outperform Rating, $405 Price Target MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,508 12,612 18,576 19,285 21,064 18,434 - -
Enterprise Value (EV) 1 5,365 8,710 13,109 13,956 14,137 15,149 13,662 12,247
P/E ratio 11.8 x 18.9 x 28.3 x 24.4 x 19.2 x 14.2 x 12.4 x 10.8 x
Yield - - - - - - - -
Capitalization / Revenue 0.51 x 0.65 x 0.67 x 0.6 x 0.62 x 0.46 x 0.43 x 0.4 x
EV / Revenue 0.32 x 0.45 x 0.47 x 0.44 x 0.41 x 0.38 x 0.32 x 0.27 x
EV / EBITDA 4.67 x 6.55 x 10.5 x 8.69 x 8.07 x 7.32 x 5.89 x 4.77 x
EV / FCF 14.5 x 4.8 x 6.42 x 20.5 x 8.96 x 9.47 x 7.05 x -
FCF Yield 6.9% 20.8% 15.6% 4.89% 11.2% 10.6% 14.2% -
Price to Book 4.29 x 5.99 x 7.01 x 6.46 x 4.97 x 3.33 x 2.63 x 2.13 x
Nbr of stocks (in thousands) 62,700 59,300 58,400 58,400 58,300 58,600 - -
Reference price 2 135.7 212.7 318.1 330.2 361.3 314.6 314.6 314.6
Announcement Date 2/10/20 2/10/21 2/9/22 2/8/23 2/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 16,829 19,423 27,771 31,974 34,072 39,666 42,548 46,137
EBITDA 1 1,148 1,330 1,244 1,606 1,751 2,068 2,319 2,568
EBIT 1 1,044 1,242 1,113 1,430 1,648 1,915 2,164 2,445
Operating Margin 6.2% 6.39% 4.01% 4.47% 4.84% 4.83% 5.09% 5.3%
Earnings before Tax (EBT) 1 972 961 875 1,063 1,464 1,726 1,979 2,259
Net income 1 737 673 659 792 1,091 1,285 1,465 1,692
Net margin 4.38% 3.46% 2.37% 2.48% 3.2% 3.24% 3.44% 3.67%
EPS 2 11.47 11.23 11.25 13.55 18.77 22.10 25.35 29.09
Free Cash Flow 1 370 1,816 2,042 682 1,578 1,600 1,939 -
FCF margin 2.2% 9.35% 7.35% 2.13% 4.63% 4.03% 4.56% -
FCF Conversion (EBITDA) 32.23% 136.57% 164.15% 42.47% 90.12% 77.38% 83.61% -
FCF Conversion (Net income) 50.2% 269.84% 309.86% 86.11% 144.64% 124.58% 132.39% -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/10/20 2/10/21 2/9/22 2/8/23 2/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 7,409 7,770 8,054 7,927 8,223 8,149 8,327 8,548 9,048 9,931 9,763 9,914 10,137 10,468 10,487
EBITDA 1 275 434 408 392 371 499 487 444 362 494 500.3 539.5 517.2 586.5 600.4
EBIT 1 240 394 367 347 324 455 445 402 346 449 461.8 502.2 483.2 547.9 562.1
Operating Margin 3.24% 5.07% 4.56% 4.38% 3.94% 5.58% 5.34% 4.7% 3.82% 4.52% 4.73% 5.07% 4.77% 5.23% 5.36%
Earnings before Tax (EBT) 1 136 344 334 307 78 427 416 332 289 399 408.1 449.6 429.6 497.3 493.8
Net income 1 103 258 248 230 56 321 309 245 216 301 309.8 336.1 314.3 375.5 372.2
Net margin 1.39% 3.32% 3.08% 2.9% 0.68% 3.94% 3.71% 2.87% 2.39% 3.03% 3.17% 3.39% 3.1% 3.59% 3.55%
EPS 2 1.740 4.390 4.250 3.950 0.9600 5.520 5.350 4.210 3.700 5.170 5.292 5.938 5.580 6.426 6.643
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/9/22 4/27/22 7/27/22 10/26/22 2/8/23 4/26/23 7/26/23 10/25/23 2/7/24 4/24/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 3,143 3,902 5,467 5,329 6,927 3,285 4,772 6,187
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 370 1,816 2,042 682 1,578 1,600 1,939 -
ROE (net income / shareholders' equity) 40.9% 33.2% 27.9% 37.5% 30.4% 27.1% 24.1% 22.4%
ROA (Net income/ Total Assets) 10.6% 8.25% 6.06% 8.55% 8.02% 8.1% 8.24% 8.31%
Assets 1 6,971 8,159 10,871 9,266 13,603 15,860 17,771 20,361
Book Value Per Share 2 31.60 35.50 45.30 51.10 72.70 94.50 119.0 148.0
Cash Flow per Share 2 6.650 - 36.20 13.20 28.60 36.10 36.50 42.10
Capex 1 57 74 77 91 84 101 104 110
Capex / Sales 0.34% 0.38% 0.28% 0.28% 0.25% 0.25% 0.24% 0.24%
Announcement Date 2/10/20 2/10/21 2/9/22 2/8/23 2/7/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Molina Healthcare, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
314.6 USD
Average target price
401 USD
Spread / Average Target
+27.47%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

1st Jan change Capi.
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-12.93% 18.43B
UNITEDHEALTH GROUP INC. Stock UnitedHealth Group Inc.
-5.91% 456B
ELEVANCE HEALTH, INC. Stock Elevance Health, Inc.
+14.19% 125B
CIGNA Stock Cigna
+15.08% 97.9B
HUMANA INC. Stock Humana Inc.
-21.78% 43.15B
CENTENE CORPORATION Stock Centene Corporation
-3.53% 38.2B
PROGYNY, INC. Stock Progyny, Inc.
-27.51% 2.57B
ALIGNMENT HEALTHCARE, INC. Stock Alignment Healthcare, Inc.
-8.59% 1.5B
Other Managed Healthcare
  1. Stock Market
  2. Equities
  3. MOH Stock
  4. Financials Molina Healthcare, Inc.